Autophagy in osteoarthritis

Joint Bone Spine. 2016 Mar;83(2):143-8. doi: 10.1016/j.jbspin.2015.06.009. Epub 2015 Oct 6.

Abstract

Degradation of the articular cartilage is at the centre of the pathogenesis of osteoarthritis (OA), for which age is the major risk factor. Maintaining the chondrocytes in a healthy condition appears to be an important factor for preservation of the entire cartilage and preventing its degeneration. Autophagy, which is an essential cellular homeostatic mechanism for the removal of dysfunctional cellular organelles and macromolecules, is increased by catabolic and nutritional stresses. Autophagy is increased in OA chondrocytes and cartilage, particularly during the initial degenerative phase, to regulate changes in OA-like gene expression through modulation of apoptosis and reactive oxygen species (ROS). In this way, autophagy acts as an adaptive response to protect chondrocytes from various environmental changes, while with gradual cartilage degradation, decreased autophagy is linked with cell death. Rapamycin, which is a specific inhibitor of the mTOR signaling pathway, enhances expression of autophagy regulators and prevents chondrocyte death. In the future, pharmacological activation of autophagy may be an effective therapeutic approach for OA.

Keywords: Autophagy; Chondrocyte; Osteoarthritis; Rapamycin.

Publication types

  • Review

MeSH terms

  • Autophagy / drug effects
  • Autophagy / physiology*
  • Cartilage, Articular / drug effects
  • Cartilage, Articular / physiology
  • Cartilage, Articular / physiopathology*
  • Chondrocytes / drug effects
  • Chondrocytes / physiology*
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use
  • Inflammation / physiopathology
  • Osteoarthritis / drug therapy
  • Osteoarthritis / physiopathology*
  • Sirolimus / pharmacology
  • Sirolimus / therapeutic use

Substances

  • Immunosuppressive Agents
  • Sirolimus